Navigation Links
Ganite in Medical News

FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia

...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors

...c patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed an oral formulation of the active ingredient in ganite that is currently undergoing initial clinical trials as a potential treatment for diseases associated with accelerated bone loss. Genta is partnered w...
Ganite in Medical Technology

Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO

BERKELEY HEIGHTS, N.J., June 04, 2007 /PRNewswire-FirstCall/ -- Genta Incorporated announced the presentation of results from a Phase 2 clinical trial of its marketed product, Ganite(R) (gallium nitrate injection), plus rituximab (Rituxan(R); Genentech/IDEC) and dexamethasone in patients with rela...

Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO

BERKELEY HEIGHTS, NJ – June 4, 2007 – Genta Incorporated (Nasdaq: GNTA) announced the presentation of results from a Phase 2 clinical trial of its marketed product, Ganite® (gallium nitrate injection), plus rituximab (Rituxan®; Genentech/IDEC) and dexamethasone in patients with ...

Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma

...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane

...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma

...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders

...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology

...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Receives Key Patent Related to Oral Gallium Compound G4544

... nitrate injection). The active ingredient in both ganite and G4544 is ionic gallium, which is reversibly in...s a mild anabolic agent to enhance bone formation. ganite is approved by the U.S. Food and Drug Administrati...ated hypercalcemia that is resistant to hydration. ganite is exclusively marketed in the U.S. by Genta and i...

Specialized Genasense(R) Clinical Trials Featured at AACR Meeting

...Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma

...The Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...
Ganite in Biological Technology

Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma

... The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights

... of a 1-for-6 reverse stock split on July 13, 2007.) Net product sales of ganite for the second quarter and six months ended June 30, 2008 of $0.1 million a...ynthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside...

Genta Announces Second Quarter 2008 Financial Results and Conference Call

... The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane

... The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia

... Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs

...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights

...CLL -- Company restructures to conserve cash -- Genta will seek buyer for ganite and terminates c-myb antisense program "Genta has successfully diversifie...hetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside...

Genta Announces Transfer of its Common Stock to the OTC Bulletin Board

... Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Announces Pending Transfer of its Common Stock to the Over-the-Counter Bulletin Board

...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...

Genta Restructures Operations to Focus on Priority Initiatives

... The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...
Other Tags
(Date:5/23/2013)... (PRWEB) May 23, 2013 Da Vinci ... in a trial in Washington State May 23, according ... clients in surgical robot lawsuits , expresses disappointment ... da Vinci lawsuits to not read a single verdict ... case (Estate of Fred E. Taylor v. Intuitive Surgical ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Amirsys, ... comprehensive radiology learning environment for all resident levels ... and assessments, transforms the learning experience from case-based ... , “Until RADPrimer 3.0, RADPrimer heavily ... none,” comments Dr. B.J. Manaster, Professor of Radiology ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... treat hip and knee osteoarthritis may have an unexpected ... a small new study of older adults suggests. ... intraocular pressure (IOP) or pressure inside the eye. Left ... blindness. In the new study of ...
(Date:5/23/2013)... News) -- A modified version of the polio ... preliminary research suggests. Scientists at Duke Cancer ... PVSRIPO, uses an engineered form of the virus ... cancer cells. The therapy shows promise in the ... brain tumor, they said. "These early results ...
(Date:5/23/2013)... eat at fast-food restaurants are consuming significantly more calories ... offenders, a new study found. "Teens underestimate the ... as 34 percent, parents of school-age children by as ... as 20 percent," study lead researcher, Dr. Jason Block, ... Johnson Foundation, which helped fund the study. ...
Breaking Medicine News(10 mins):Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:RADPrimer 3.0 Introduces Comprehensive Radiology Training Curriculum 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:Modified Polio Virus May Help Fight Brain Tumors, Study Suggests 2Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2
(Date:5/23/2013)... RICHLAND, Wash. Pacific Northwest National Laboratory honored ... and commercialization of intellectual property at PNNL,s annual ... , The Department of Energy national laboratory ... Year for his work developing battery materials that ... to the electrical grid, and reduce the time ...
(Date:5/23/2013)... more than 284 million tons of cargo, transit the Panama ... fees for the Panama Canal Authority. Each time a ship ... used from Gatun Lake, which is also a source of ... , However, the advent of very large "super" cargo ... sea, has demanded change. The Panama Canal is being expanded ...
(Date:5/23/2013)... Investigators at Rollins School of Public Health at ... Institute of Technology, have received a $4 million ... Center at Emory University (Health and Exposome Research ... first exposome-based center grant awarded in the United ... by the National Institute of Environmental Health Sciences ...
Breaking Biology News(10 mins):PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
Other Contents